Nanobiotix S.A. (NBTX)
3.31
-0.25 (-7.02%)
At close: Mar 04, 2025, 11:45 AM
Nanobiotix S.A. Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -39.7M | -57.04M | -47M | -33.59M | -50.91M | -30.34M | -26.14M | -21.88M | -17M | -9.56M | -8.14M | -5.33M | -5.25M |
| Depreciation & Amortization | 1.51M | 1.5M | 1.56M | 1.75M | 1.77M | 619K | 403.85K | 482.79K | 456.08K | 307.56K | 233.93K | 146.53K | 197.62K |
| Stock-Based Compensation | 3.3M | 3.17M | 3.2M | 2.92M | 4.32M | 1.87M | 2.61M | 1.99M | 1.29M | 252.26K | 597.96K | 451.2K | 266.26K |
| Other Working Capital | 2.05M | 2.4M | 11.48M | 124K | -1.44M | 934K | 1.84M | 1.12M | -1.5M | 376.9K | 499.91K | n/a | n/a |
| Other Non-Cash Items | 12.37M | 12.96M | 678K | -4.34M | 3.08M | 796K | 430.32K | -75.17K | 8.56K | 55.73K | -17.89K | 33.87K | -4.24K |
| Deferred Income Tax | 120K | n/a | 152K | 5.64M | 2.1M | n/a | n/a | n/a | n/a | -1 | -1 | n/a | n/a |
| Change in Working Capital | 9.92M | 2.3M | 11.54M | 73K | -1.52M | 1.08M | 1.67M | 1.2M | -1.57M | 376.16K | 500.36K | 913.55K | -86.3K |
| Operating Cash Flow | -12.48M | -37.1M | -29.87M | -27.54M | -41.17M | -25.98M | -21.03M | -18.28M | -16.82M | -8.56M | -6.83M | -3.79M | -4.87M |
| Capital Expenditures | -337K | -93K | -233K | -107K | -1.44M | -506K | -1.46M | -400.1K | -1.49M | -963.26K | -196.32K | -45.39K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 72.95K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -9K | -4K | -16K | n/a | -1.46M | -444.99K | -2.28M | -1.14M | -195.87K | -50.83K | -81.02K |
| Sales Maturities Of Investments | n/a | 231K | n/a | n/a | n/a | 577K | n/a | n/a | n/a | n/a | n/a | n/a | 5.03M |
| Other Investing Acitivies | -21K | 1K | -14K | -1K | 1K | 577K | -224K | -44.88K | 72.95K | 42.00 | 3.55K | 1.32K | n/a |
| Investing Cash Flow | -349K | 138K | -242K | -112K | -1.46M | 71K | -1.46M | -444.99K | -2.21M | -1.14M | -192.31K | -49.51K | 4.95M |
| Debt Repayment | -3.62M | -4.74M | -3.74M | 9.17M | 12.43M | 15.07M | -1.03M | 1.22M | 2.29M | 1.19M | -365K | 647.5K | 151.15K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.39K | -19.78M | -1.89M | -1.11M | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -9.77M | -916K | -1.44M | -11.05M | -461K | -223K | -3.56M | -1.43M | 417K | -2.17M | 8.12K | -2.05M | 11.53K |
| Financial Cash Flow | 46.77M | -5.65M | -5.18M | 111.77M | 41.49M | 14.85M | 48.53M | 22.9M | 3.06M | 37.71M | -358.13K | 15.3M | 177.37K |
| Net Cash Flow | 33.9M | -42.53M | -35.23M | 84.06M | -1.11M | -11.01M | 26.15M | 4.05M | -15.98M | 28.01M | -7.38M | 11.46M | 249.66K |
| Free Cash Flow | -12.81M | -37.2M | -30.11M | -27.64M | -42.61M | -26.49M | -22.5M | -18.68M | -18.32M | -9.53M | -7.03M | -3.83M | -4.87M |